Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of norepinephrine and dobutamine in patients with cardiogenic shock
2020-004881-20Phase 4Active
- Sponsor
- Azienda USL Toscana Sud Est
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cardiogenic shock comparing Norepinephrine arm with Dobutamine arm (2 arms). Primary endpoint: Change in blood lactate concentration at 72 hours. Started Jun 2021; status: active.
02
Drugs
norepinephrinedobutamine
03
Conditions
cardiogenic shock
Beyond the preview
Go deeper on 2020-004881-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004881-20.